Similar to CD59, the binding of the fluid phase RCAs to viral surfaces is thought to contribute to the inhibition of complement activation and thus mediate protection of viruses to CML. Here, CD59 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.